MedTrace Logo

An Educational Intervention Program to Improve the Oral Health of HIV-Positive Children in Kano, Nigeria.

NCT05540171 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2024-03-07

No results posted yet for this study

Summary

The aim of this 2- arm randomized-control study is to determine the effect of an oral hygiene self care intervention on the oral health status and oral health-related quality of life (OHRQoL) of HIV-positive children (age: 8-16 years, n=172) presenting to five pediatric HIV clinics in Kano, Nigeria.

The intervention will comprise oral health education and instructions on oral self-care.

Data on oral health status and OHRQoL will be obtained at baseline and at 1, 3 and 6 months.

Study findings will help inform policies to improve the oral health and OHRQoL of HIV-positive Nigerian children and guide the integration of oral health care services into HIV programs.

Conditions

  • HIV
  • Dental Caries
  • Quality of Life
  • Oral Disease
  • Oral Infection
  • Oral Manifestations

Interventions

OTHER

Oral health education and instructions/training for self-oral care

Education intervention

Sponsors & Collaborators

  • NIH Office of AIDS Research (OAR)

    collaborator NIH

  • Fogarty International Center of the National Institute of Health

    collaborator NIH

  • Aminu Kano Teaching Hospital

    lead OTHER

Principal Investigators

  • Yewande I ADEYEMO, BDS · Bayero University, Kano/ Aminu Kano Teaching Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-22
Primary Completion
2023-09-15
Completion
2023-09-15

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05540171 on ClinicalTrials.gov